Research & Technology
March 4, 2024
Corewell Health and BAMF Health Partner on Clinical Trial to Test Targeted Radiation Therapy for Cancer Patients
GRAND RAPIDS, Mich, March 4, 2024 — BAMF Health, a world leader in molecular imaging and theranostics, and Corewell Health™ Haworth Innovative Therapeutics Clinic are partnering on their first collaborative clinical trial to investigate a new targeted liquid radiation therapy that could provide a better treatment option for cancer patients whose chemotherapy treatments have been […]
January 17, 2024
Corewell Health Treats First Patients in Hypertension Clinical Trial
November 14, 2023
Corewell Health and MSU Fund Nearly $1.4 Million in New Research Grants to Advance Therapies for Patients
Grand Rapids, Mich., Nov. 14, 2023 – Corewell Health in West Michigan and Michigan State University College of Human Medicine are funding nearly $1.4 million in new research grants that will tackle potential new therapies for diseases including cancer, coronary artery disease and more. Thanks to the help of a long-standing partnership known as the […]
October 18, 2023
Simple MRI scan could predict radiation side effects for prostate cancer
A new Corewell Health study suggests that men who have longer prostatic urethras, the part of the urethra that travels through the prostate, may be at a higher risk of experiencing moderate, often chronic urinary side effects after receiving radiation for prostate cancer. To date, researchers have struggled to determine any risk factors that could […]
May 15, 2023
After discovery of rare disease, doctors invent successful treatment in just 15 months
Grand Rapids, Mich., May 15, 2023 – For a handful of children worldwide who have an ultra-rare disease called Bachmann-Bupp syndrome, a treatment regimen discovered in just 15 months by the team who identified the disease is dramatically changing their young lives. Now, two Corewell Health physicians are part of a group who has been […]
April 18, 2023
New research may hold key to better treatments for aggressive brain cancer
Southfield, Mich., April 18, 2023 – For decades, researchers have marveled at the ability of glioblastoma, a particularly aggressive brain cancer, to turn off a patient’s cancer-fighting immune cells, thereby allowing tumors to grow freely. This remains a primary reason why there are very few effective therapies available for this mostly fatal disease. In a […]
March 2, 2023
Corewell Health participates in national effort to expedite delivery of proven research results to doctors, patients
SOUTHFIELD and GRAND RAPIDS, Mich., March 2, 2023 – Corewell Health is one of 42 health systems nationwide that has been selected to investigate strategies that will cut the time it takes for published and proven research results to be made available in the clinical setting. The work is part of a pioneering initiative developed […]
February 6, 2023
Corewell Health enrolls 10,000th participant in All of Us Research Program
Grand Rapids, Mich., February 6, 2023 – Corewell Health TM has enrolled its 10,000th participant in the All of Us Research Program, the largest study of its kind in U.S. history. Participation of the West Michigan community is helping the study reach the target of one million participants. Corewell Health in Grand Rapids is one […]
June 6, 2022
Spectrum Health Hyperbaric and Dive Medicine expanding with new multiplace hyperbaric chamber
Grand Rapids, Mich., June 6, 2022 – Spectrum Health Hyperbaric and Dive Medicine is expanding with the arrival of a new multiplace hyperbaric chamber that can accommodate up to eight patients at once. The new department and chamber will be located at 330 Barclay Avenue in Grand Rapids. This chamber replaces the current monoplace, or […]
July 28, 2021
Spectrum Health First in Nation to Treat Epilepsy Patient with New Device
Grand Rapids, Mich., July 28, 2021 – Spectrum Health has employed a new and sophisticated medical device to ease some symptoms associated with medically refractory epilepsy and certain movement disorders, making it the first hospital in the nation to use the device to treat a patient with epilepsy and the first in the state of […]
February 2, 2021
Spectrum Health Offers COVID-19 Treatments to Promote Recovery
GRAND RAPIDS, Mich., Feb. 2, 2021 – Spectrum Health West Michigan will open an infusion clinic at Spectrum Health Blodgett Hospital on Feb. 10 that uses monoclonal antibodies for the treatment of COVID-19 under a U.S. Food and Drug Administration Emergency Use Authorization. The infusion treatment features Eli Lilly’s Bamlanivimab and Regeneron’s Casirivimab and Imdevimab combination. Bamlanivimab also is being used at Spectrum Health Lakeland to treat COVID-19 patients as part of their COVID-19 Medication Therapies […]
January 28, 2021
Spectrum Health Offers New Treatment for COPD
GRAND RAPIDS, Mich., Jan. 28, 2021 – Spectrum Health is the first health system in West Michigan to offer targeted lung denervation, an investigational treatment option for patients with chronic obstructive pulmonary disease, or COPD. Targeted lung denervation (TLD) is a bronchoscopic intervention designed to disrupt pulmonary nerve reflexes, which may have the potential to […]
October 29, 2020
Spectrum Health Enrolling Patients in Clinical Trial for Inpatient COVID-19 Treatment
GRAND RAPIDS Mich., Oct. 29, 2020 – Spectrum Health is partnering with Regeneron Pharmaceuticals to enroll patients into a clinical trial evaluating REGN-COV2, the company’s investigational antibody cocktail for the treatment and prevention of COVID-19. Spectrum Health is the only health system in West Michigan and one of only two in the state to offer […]
October 27, 2020
Spectrum Health to Participate in the HEALEY ALS Platform Trial, the First of Its Kind for ALS
GRAND RAPIDS, Mich., Oct. 27, 2020 – Spectrum Health is one of 54 sites of the Northeast ALS Consortium (NEALS), which has received approval from the U.S. Food and Drug Administration (FDA) to proceed with administering three proposed drug regimens in the HEALEY ALS Platform Trial – the first trial of its kind for amyotrophic […]
May 8, 2020
Minority Children with Cancer in PICU’s Show Higher Death Rates
GRAND RAPIDS, Mich., May 8, 2020 – A new study led by Spectrum Health physician researchers shows that minority children with cancer admitted to pediatric intensive care units (PICUs) throughout the nation have higher death rates than their Caucasian counterparts. The study found that mortality rates for African American (8.5 percent) and Hispanic children (8.1 […]
In The News
February 29, 2024